arrow
返回
M

Moshe Talpaz

University of Michigan Rogel Cancer Center

124H指数
1.3K论文数
7.3W被引数
收录论文 203
发表时间
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final resultsAsciminib单药治疗BCR::ABL1 T315I突变慢性期慢性粒细胞白血病:1期试验最终结果
errLeukemia
IF13.4
err2026-07-16
err0
errOAAI
errJorge E. Cortes; Delphine Rea; Michael J. Mauro; Andreas Hochhaus; Dong-Wook Kim; Koji Sasaki; Fabian Lang; Michael C. Heinrich; Massimo Breccia; Michael Deininger; Yeow-Tee Goh; Jeroen J. W. M. Janssen; Moshe Talpaz; Valle Gómez García de Soria; Philipp le Coutre; Francois-Xavier Mahon; Daniel J. DeAngelo; Andrea Damon; Shruti Kapoor; Gessami Sanchez-Olle; Matthias Hoch; Nithya Agrawal; Sara Quenet; Timothy P. Hughes
err分享
err收藏
From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia从致命性疾病到功能性治愈:慢性髓性白血病酪氨酸激酶抑制25年
errLeukemia
IF13.4
err2026-05-22
err0
errOAAI
errAndreas Hochhaus; Moshe Talpaz; Giuseppe Saglio; Jorge E. Cortes; Timothy Hughes; Jane Apperley; Oliver Hantschel; Delphine Rea; Peter Schuld; Hagop Kantarjian
err分享
err收藏
Activity of PROTAC MDM2 degrader in primary leukemia cells and PDX modelsPROTAC MDM2降解剂在原代白血病细胞和PDX模型中的活性
errLeukemia
IF13.4
err2026-04-15
err0
errOAAI
errMalathi Kandarpa; Luke F. Peterson; Harish Potu; Megha Ramappan; Yihong Liu; Avery Polk; Shaomeng Wang; Moshe Talpaz
err分享
err收藏
Effects of calreticulin mutations on HLA class I expression in myeloproliferative neoplasms钙网蛋白突变对骨髓增殖性肿瘤中HLA I类表达的影响
err2025-11-01
err0
PREAI
errKaur, Amanpreet; Pagnucco, Grace; Desikan, Harini; Kandarpa, Malathi; Talpaz, Moshe; Raghavan, Malini
err分享
err收藏
Quantitative MRI Assessment of Bone Marrow Disease in Myelofibrosis: A Prospective Study
err2025-11-01
err0
PREAI
errRobison, Tanner H.; Levinson, Annabel; Lee, Winston; Pettit, Kristen; Malyarenko, Dariya; Kandarpa, Malathi; Johnson, Timothy D.; Chenevert, Thomas L.; Ross, Brian D.; Talpaz, Moshe; Luker, Gary D.
err分享
err收藏
Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trialPelabresib联合ruxolitinib治疗JAK抑制剂初治骨髓纤维化:一项随机III期试验
err2025-03-10
err2
errOAAI
errRampal, Raajit K.; Grosicki, Sebastian; Chraniuk, Dominik; Abruzzese, Elisabetta; Bose, Prithviraj; Gerds, Aaron T.; Vannucchi, Alessandro M.; Palandri, Francesca; Lee, Sung-Eun; Gupta, Vikas; Lucchesi, Alessandro; Oh, Stephen T.; Kuykendall, Andrew T.; Patriarca, Andrea; alvarez-Larran, Alberto; Mesa, Ruben; Kiladjian, Jean-Jacques; Talpaz, Moshe; Scandura, Joseph M.; Lavie, David; Harris, Morgan; Kays, Sarah-Katharina; Li, Qing; Boxhammer, Rainer; Brown, Barbara; Jegg, Anna-Maria; Harrison, Claire N.; Mascarenhas, John
err分享
err收藏
Biomarkers of Renal Health in Patients (pts) Treated with Fedratinib in the FREEDOM and FREEDOM2 TrialsFedratinib治疗的FREEDOM和FREEDOM2试验中患者的肾脏健康生物标志物
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errGupta, Vikas; Chen, Yizhe; Brown, Patrick; Jeyaraju, Danny; Talpaz, Moshe; Mesa, Ruben; Pilot, Richard; Hernandez, Christopher; Wang, Jia; Kiladjian, Jean-Jacques; Vannucchi, Alessandro; Harrison, Claire
err分享
err收藏
Updated Results from the Phase 3 Manifest-2 Study of Pelabresib in Combination with Ruxolitinib for Janus Kinase Inhibitor-Naive Patients with Myelofibrosis佩拉布雷昔布与鲁索利替尼联合治疗Janus激酶抑制剂初治骨髓纤维化患者的III期Manifest-2研究最新结果
errBLOOD
IF23.1
err2024-11-05
err2
PREAI
errMascarenhas, John O.; Grosicki, Sebastian; Chraniuk, Dominik; Abruzzese, Elisabetta; Bose, Prithviraj; Gerds, Aaron T.; Vannucchi, Alessandro M.; Palandri, Francesca; Lee, Sung-Eun; Gupta, Vikas; Lucchesi, Alessandro; Oh, Stephen; Kuykendall, Andrew T.; Patriarca, Andrea; Alvarez-Larran, Alberto; Mesa, Ruben; Kiladjian, Jean-Jacques; Talpaz, Moshe; Harris, Morgan; Kays, Sarah-Katharina; Li, Qing; Brown, Barbara; Jegg, Anna-Maria; Harrison, Claire; Rampal, Raajit
err分享
err收藏
A Phase 1/2 Study of Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor, in Combination with JAK Inhibitors Ruxolitinib or Momelotinib in Patients with Myelofibrosis一项关于Nuvisertib(TP-3654)的1/2期研究,Nuvisertib是一种实验性选择性PIM1激酶抑制剂,与JAK抑制剂Ruxolitinib或Momelotinib联合用于骨髓纤维化患者。
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errMascarenhas, John O.; Rampal, Raajit; El Chaer, Firas; Gupta, Vikas; Shimoda, Kazuya; Kiladjian, Jean-Jacques; Passamonti, Francesco; Bose, Prithviraj; Scandura, Joseph M.; Mesa, Ruben; Rein, Lindsay A. M.; Yuda, Junichiro; Ross, David M.; Devos, Timothy; Talpaz, Moshe; Hoffman, Ronald; Kabir, Sujan; Li, Zhonggai; Foulks, Jason M.; Ansaldo, Karen; Seki, Masataka; Peddagali, Vishnu; Shah, Jatin; Harrison, Claire
err分享
err收藏
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3trial
err2024-10-01
err3
PREAI
errHarrison, Claire N.; Mesa, Ruben; Talpaz, Moshe; Al-Ali, Haifa Kathrin; Xicoy, Blanca; Passamonti, Francesco; Palandri, Francesca; Benevolo, Giulia; Vannucchi, Alessandro Maria; Mediavilla, Clemence; Iurlo, Alessandra; Kim, Inho; Rose, Shelonitda; Brown, Patrick; Hernandez, Christopher; Wang, Jia; Kiladjian, Jean-Jacques
err分享
err收藏
Correction: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials更正: 来自PACE和OPTIC试验的慢性期慢性粒细胞白血病 (cp-cml) 患者的泊那替尼剂量修改动力学
errLEUKEMIA
IF13.4
err2024-09-02
err0
errOAAI
errJabbour, Elias; Apperley, Jane; Cortes, Jorge; Rea, Delphine; Deininger, Michael; Abruzzese, Elisabetta; Chuah, Charles; Deangelo, Daniel J.; Hochhaus, Andreas; Lipton, Jeffrey H.; Mauro, Michael; Nicolini, Franck; Pinilla-Ibarz, Javier; Rosti, Gianantonio; Rousselot, Philippe; Shah, Neil P.; Talpaz, Moshe; Vorog, Alexander; Ren, Xiaowei; Kantarjian, Hagop
err分享
err收藏
Lysosomal degradation targets mutant calreticulin and the thrombopoietin receptor in myeloproliferative neoplasms
err2024-06-26
err0
errOAAI
errKaur, Amanpreet; Venkatesan, Arunkumar; Kandarpa, Malathi; Talpaz, Moshe; Raghavan, Malini
err分享
err收藏
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results在酪氨酸激酶抑制剂治疗 ≥ 1个T315I突变的慢性期慢性粒细胞白血病患者中单药治疗: 2年随访结果
errLEUKEMIA
IF13.4
err2024-05-16
err8
errOAAI
errCortes, Jorge E.; Sasaki, Koji; Kim, Dong-Wook; Hughes, Timothy P.; Etienne, Gabriel; Mauro, Michael J.; Hochhaus, Andreas; Lang, Fabian; Heinrich, Michael C.; Breccia, Massimo; Deininger, Michael; Goh, Yeow Tee; Janssen, Jeroen J. W. M.; Talpaz, Moshe; de Soria, Valle Gomez Garcia; le Coutre, Philipp; Deangelo, Daniel J.; Damon, Andrea; Cacciatore, Silvia; Polydoros, Fotis; Agrawal, Nithya; Rea, Delphine
err分享
err收藏
Methodological challenges in the development of endpoints for myelofibrosis clinical trials
err2024-05-01
err2
PREAI
errBarosi, Giovanni; Tefferi, Ayalew; Gangat, Naseema; Szuber, Natasha; Rambaldi, Alessandro; Odenike, Olatoyosi; Kroeger, Nicolaus; Gagelmann, Nico; Talpaz, Moshe; Kantarjian, Hagop; Gale, Robert Peter
err分享
err收藏
Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia (vol 107, pg 1599, 2022)
err2024-04-01
err0
errOAAI
errVerstovsek, Srdan; Mesa, Ruben; Talpaz, Moshe; Kiladjian, Jean-Jacques; Harrison, Claire N.; Oh, Stephen T.; Vannucchi, Alessandro M.; Rampal, Raajit; Scott, Bart L.; Buckley, Sarah A.; Craig, Adam R.; Roman-Torres, Karisse; Mascarenhas, John O.
err分享
err收藏
Combined mek and jak inhibition in vitro is an effective strategy in overcoming jak inhibitor resistance in primary myelofibrosis (PMF)
err2024-03-22
err0
PREAI
errReynolds, Samuel Benjamin; Matono, Sho; Kandarpa, Malathi; Pettit, Kristen; Ribick, Mark; Talpaz, Moshe; Li, Qing
err分享
err收藏
Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations
err2024-02-22
err2
errOAAI
errKandarpa, Malathi; Robinson, Dan; Wu, Yi-Mi; Qin, Tingting; Pettit, Kristen; Li, Qing; Luker, Gary; Sartor, Maureen; Chinnaiyan, Arul; Talpaz, Moshe
err分享
err收藏
ctDNA transiting into urine is ultrashort and facilitates noninvasive liquid biopsy of HPV+ oropharyngeal cancer
err2024-02-08
err5
errOAAI
errBhambhani, Chandan; Kang, Qing; Hovelson, Daniel H.; Sandford, Erin; Olesnavich, Mary; Dermody, Sarah M.; Wolfgang, Jenny; Tuck, Kirsten L.; Brummel, Collin; Bhangale, Apurva D.; He, Kuang; Gutierrez, Marc G.; Lindstrom, Ryan H.; Liu, Chia-Jen; Tuck, Melissa; Kandarpa, Malathi; Mierzwa, Michelle; Casper, Keith; Prince, Mark E.; Krauss, John C.; Talpaz, Moshe; Henry, N. Lynn; Giraldez, Maria D.; Ramnath, Nithya; Tomlins, Scott A.; Swiecicki, Paul L.; Brenner, J. Chad; Tewari, Muneesh
err分享
err收藏
Chronic Myeloid Leukemia, Version 2.2024慢性粒细胞白血病2.2024版
err2024-02-01
err16
errOAAI
errShah, Neil P.; Bhatia, Ravi; Altman, Jessica K.; Amaya, Maria; Begna, Kebede H.; Berman, Ellin; Chan, Onyee; Clements, Joan; Collins, Robert H., Jr.; Curtin, Peter T.; DeAngelo, Daniel J.; Drazer, Michael; Maness, Lori; Metheny, Leland; Mohan, Sanjay; Moore, Joseph O.; Oehler, Vivian; Pratz, Keith; Pusic, Iskra; Rose, Michal G.; Shomali, William; Smith, B. Douglas; Styler, Michael; Talpaz, Moshe; Tanaka, Tiffany N.; Tantravahi, Srinivas; Thompson, James; Tsai, Steven; Vaughn, Jennifer; Welborn, Jeanna; Yang, David T.; Sundar, Hema; Gregory, Kristina
err分享
err收藏
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials来自PACE和OPTIC试验的慢性期慢性粒细胞白血病 (cp-cml) 患者的ponatinib剂量修改动力学
errLEUKEMIA
IF13.4
err2024-01-29
err13
errOAAI
errJabbour, Elias; Apperley, Jane; Cortes, Jorge; Rea, Delphine; Deininger, Michael; Abruzzese, Elisabetta; Chuah, Charles; Deangelo, Daniel J.; Hochhaus, Andreas; Lipton, Jeffrey H.; Mauro, Michael; Nicolini, Franck; Pinilla-Ibarz, Javier; Rosti, Gianantonio; Rousselot, Philippe; Shah, Neil P.; Talpaz, Moshe; Vorog, Alexander; Ren, Xiaowei; Kantarjian, Hagop
err分享
err收藏